(Q41263504)

28 September 2017

6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys (English)

1 reference

28 September 2017

D J Doudet

1

1 reference

28 September 2017

H Miyake

2

1 reference

28 September 2017

R T Finn

3

1 reference

28 September 2017

C A McLellan

4

1 reference

28 September 2017

T G Aigner

5

1 reference

28 September 2017

R Q Wan

6

1 reference

28 September 2017

H R Adams

7

1 reference

28 September 2017

R M Cohen

8

1 reference

28 September 2017

1 January 1989

1 reference

28 September 2017

12

1 reference

Experimental Brain Research

inferred from page(s)

published in

1 reference

28 September 2017

78

1 reference

28 September 2017

1

1 reference

28 September 2017

69-80

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00230688

28 September 2017

0 references

cites work

The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture.

1 reference

12 December 2020

Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection

1 reference

12 December 2020

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

1 reference

12 December 2020

Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography

1 reference

12 December 2020

MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study.

1 reference

12 December 2020

Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease

1 reference

12 December 2020

Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.

1 reference

12 December 2020

Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

1 reference

12 December 2020

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

1 reference

12 December 2020

The site of dopamine formation in rat striatum after L-dopa administration

1 reference

12 December 2020

Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease

1 reference

12 December 2020

Striatal dopamine distribution in parkinsonian patients during life.

1 reference

12 December 2020

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

12 December 2020

Routine synthesis of L-[18F]6-fluorodopa with fluorine-18 acetyl hypofluorite

1 reference

12 December 2020

Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease

1 reference

12 December 2020

A new autoradiographic approach for imaging forebrain dopamine distribution.

1 reference

12 December 2020

MPTP: current concepts and controversies

1 reference

12 December 2020

18 FFluoro-dopa, an analogue of dopa, and its use in direct external measurements of storage, degradation, and turnover of intracerebral dopamine

1 reference

12 December 2020

6-Fluorocatecholamines as false adrenergic neurotransmitters

1 reference

12 December 2020

Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.

1 reference

12 December 2020

Regional cerebral blood flow in patients with Parkinson's disease under chronic levodopa therapy: measurements during "on" and "off" response fluctuations

1 reference

12 December 2020

[18F]fluoro-L-dopa for the in vivo study of intracerebral dopamine.

1 reference

12 December 2020

Dopamine visualized in the basal ganglia of living man.

1 reference

12 December 2020

Striatal dopamine metabolism in living monkeys examined by positron emission tomography.

1 reference

12 December 2020

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

1 reference

12 December 2020

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

1 reference

12 December 2020

The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study

1 reference

12 December 2020

N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism.

1 reference

12 December 2020

Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].

1 reference

12 December 2020

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

12 December 2020

Aetiology of Parkinson's disease

1 reference

12 December 2020

Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.

1 reference

12 December 2020

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

Regional impairment of cerebral oxidative metabolism in Parkinson's disease

1 reference

12 December 2020

Blood-brain barrier transport and cerebral utilization of dopa in living monkeys.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00230688

1 reference

28 September 2017

1 reference